Nplate (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia

THOUSAND OAKS, Calif., Oct. 18, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) approved Amgen ' s Supplemental Biologics License Application (sBLA) for...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news